{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:04:11Z","timestamp":1789909451111,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ygyno.2013.03.010","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T10:53:04Z","timestamp":1363776784000},"page":"86-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type"],"prefix":"10.1016","volume":"130","author":[{"given":"C.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Doret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Massardier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hajri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Raudrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Golfier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.03.010_bb0005","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/humrep\/deq052","article-title":"The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles","volume":"25","author":"Baasanjav","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0010","first-page":"732","article-title":"Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation","volume":"101","author":"Feltmate","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajog.2006.10.867","article-title":"First epidemiological data from the French Trophoblastic Disease Reference Center","volume":"196","author":"Golfier","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1479-828X.2006.00538.x","article-title":"Guidelines following hydatidiform mole: a reappraisal","volume":"46","author":"Kerkmeijer","year":"2006","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-0528.2007.01320.x","article-title":"Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit","volume":"114","author":"Sebire","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","article-title":"Choriocarcinoma and partial hydatidiform moles","volume":"356","author":"Seckl","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1479-828X.2006.00539.x","article-title":"Persistent trophoblast disease following partial molar pregnancy","volume":"46","author":"Wielsma","year":"2006","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000136099.21216.45","article-title":"Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy","volume":"104","author":"Wolfberg","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000227754.12848.4e","article-title":"Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy","volume":"108","author":"Wolfberg","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"Committee. FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"Oncology","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0060","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(86)90179-0","article-title":"HM in England and Wales 1973\u20131983","volume":"2","author":"Bagshawe","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0301-2115(03)00274-4","article-title":"How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data","volume":"112","author":"Batorfi","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0075","first-page":"1","article-title":"Hydatidiform mole: diagnosis, management, and long-term follow up of 347 patients","volume":"45","author":"Curry","year":"1975","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2007.03.010","article-title":"Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands","volume":"106","author":"Kerkmeijer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ajog.2004.12.080","article-title":"Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles","volume":"192","author":"Lavie","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0002-9378(83)91202-4","article-title":"Natural history of hydatidiform mole after primary evacuation","volume":"145","author":"Lurain","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0095","series-title":"Maladies Trophoblastiques Gestationnelles, collection Recommandations et R\u00e9f\u00e9rentiels, ouvrage collectif \u00e9dit\u00e9 par l'INCa","author":"INCa","year":"2010"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0100","article-title":"Practice Bulletin Clinical Management Guidelines for obstetricians\u2013gynecologists","volume":"Number 53","author":"ACOG","year":"2004"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0105","first-page":"434","article-title":"Gestational trophoblastic disease; Society of Obstetricians and Gynaecologists of Canada; Gynaecologic Oncologists of Canada; Society of Canadian Colposcopists","volume":"24","author":"Gerulath","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0110","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1067\/mob.2003.297","article-title":"Postmolar surveillance at a trophoblastic disease center that serves indigent women","volume":"188","author":"Allen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0115","first-page":"940","article-title":"Poor compliance with postmolar surveillance and treatment protocols by indigent women","volume":"96","author":"Massad","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0125","first-page":"793","article-title":"The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers","volume":"51","author":"Cole","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0130","first-page":"538","article-title":"A plea for the creation of trophoblastic disease reference centers in France","volume":"29","author":"Golfier","year":"2000","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ygyno.2013.03.010_bb0135","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/humrep\/der265","article-title":"Contribution of referent pathologists to the quality of trophoblastic diseases diagnosis","volume":"26","author":"Golfier","year":"2011","journal-title":"Hum Reprod"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:32:43Z","timestamp":1758771163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0090825813001595"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.03.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}